Monographs: Pharmaceutical substances: Mefloquine hydrochloride (Mefloquini hydrochloridum)2015-01
C17H16F6N2O,HCl Relative molecular mass. 414.8 Chemical name. rac-(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2S)-piperidin-2-yl]methanol monohydrochloride; dl-erythro-α-2-piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride; (R*,S*)-(±)-α-piperidin-2-yl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride; CAS Reg. No. 51773-92-3. Description. A white to slightly yellow, crystalline powder. Solubility. Very slightly soluble in water; freely soluble in methanol R; soluble in ethanol (~750 g/L) TS; sparingly soluble in dichloromethane R. Category. Antimalarial. Storage. Mefloquine hydrochloride should be kept in a tightly closed container, protected from light. Additional information. Mefloquine hydrochloride may exhibit polymorphism. It melts at about 260 °C, with decomposition. Requirements Mefloquine hydrochloride contains not less than 99.0% and not more than 101.0% of C17H16F6N2O,HCl, calculated with reference to the anhydrous substance. Identity tests
Heavy metals. Use 1.0 g for the preparation of the test solution as described under 2.2.3 Limit test for heavy metals, procedure 3; determine the heavy metals content according to method A; not more than 20 μg/g. Sulfated ash. (2.3) Not more than 1.0 mg/g. Water. Determine as described under 2.8 Determination of water by the Karl Fischer method, method A, using 250 mg of the substance; the water content is not more than 30 mg/g. Related substances Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography using a stainless steel column (25 cm x 4.6 mm) packed with particles of silica gel, the surface of which has been modified with chemically-bonded octadecylsilyl groups (5 μm). As the mobile phase use a mixture of 22 volumes of methanol R, 38 volumes of acetonitrile R and 40 volumes of buffer pH 3.5 prepared as follows: dissolve 13.6 g potassium dihydrogen phosphate in about 900 mL of water R, adjust the pH to 3.5 by addition of phosphoric acid (~105 g/L) TS and dilute to 1000 mL. Prepare the following solutions in the mobile phase. For solution (1) use about 2.2 mg of the test substance per mL. For solution (2) dilute a suitable volume of solution (1) to obtain a concentration equivalent to 4.4 μg of Mefloquine hydrochloride per mL. For solution (3) use about 0.22 mg of mefloquine hydrochloride RS and about 0.04 mg of sulfadoxine R per mL. Operate with a flow rate of 1.5 mL per minute. As a detector use an ultraviolet spectrophotometer set at a wavelength of about 283 nm. Inject 20 μL of solution (3). The test is not valid unless the resolution between the two principal peaks is at least 5. Inject alternately 20 µL each of solutions (1) and (2). Record the chromatograms for about 10 times the retention time of mefloquine. In the chromatogram obtained with solution (1) the following impurities, if present, are eluted at the following relative retention with reference to mefloquine (retention time about 3.9 minutes): impurity A about 0.9; impurity C about 3.6; and impurity B about 7.4. In the chromatogram obtained with solution (1):
Assay Dissolve 0.350 g, accurately weighed, in 15 mL of anhydrous formic acid R and add 40 mL of acetic anhydride R. Titrate with perchloric acid (0.1 mol/L) VS, determining the end-point potentiometrically. Each mL of perchloric acid (0.1 mol/L) VS is equivalent to 41.48 mg of C17H17ClF6N2O. Impurities A. rac-(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol (threo-mefloquine) B. [2,8-bis(trifluoromethyl)quinolin-4-yl](pyridin-2-yl)methanone C. rac-(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl](pyridin-2-yl)methanol
|